Molly L. Shen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Molly L. Shen has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
- David Juncker
McGill University
13 shared publications - Andy Ng
Biomedical Engineering Department, McGill University, Montreal, QC, Canada
6 shared publications - Félix Lussier
Biomedical Engineering Department McGill University 3775 Rue University Montréal QC H3A 2B4 Canada
4 shared publications - Philippe DeCorwin-Martin
Biomedical Engineering Department, McGill University, Montreal, QC, Canada
4 shared publications - Vahid Karamzadeh
Aerospace Manufacturing Technology Center, National Research Council Canada, Montreal, QC, H3T 2B2, Canada
4 shared publications - Andreas Wallucks
Biomedical Engineering Department, McGill University, Montreal, QC, Canada
3 shared publications
Latest Publications
- Open Access
Multiphase capillarics for structurally pre-programmed sequential and parallel operations of high and low cohesion liquids
Capillaric circuits (CCs) enable pre-programmed liquid handling through self-filling and passive valving governed by capillary forces, eliminating the need for external pumps and actuators. However, CCs optimized for high cohesion liquids (HCL) such as water are intrinsically unsuitable for programmed flow control of low cohesion liquids (LCL) such as oils and solvents because the high surface free energy needed for capillary flow of HCL results in uncontrolled, complete wetting by LCL. Here, we introduce a library of multiphase components including phase-to-phase valves (P2PV), hydro-pneumatic relays (HPR) and multiphase domino valves (MDVs) that collectively enable CCs to concomitantly process HCLs and LCLs. P2PVs use a pre-filled HCL to valve immiscible LCLs (e.g. oil) by confining the LCL, and upon triggering, hydraulically entrain it. To prevent uncontrolled mixing between miscible LCLs (e.g. ethanol) and the HCL, HPRs with an air gap and air waste are added to the P2PV. MDVs are further added and enable preprogrammed, sequential delivery of LCL and HCL by multiphase microfluidic chain reactions. Multiphase liquid processing is applied to automated, on-chip lipid nanoparticle (LNP) manufacturing, illustrating the potential of multiphase CCs.
Open AccessMultiphase capillarics for structurally pre-programmed sequential and parallel operations of high and low cohesion liquids
Capillaric circuits (CCs) enable pre-programmed liquid handling through self-filling and passive valving governed by capillary forces, eliminating the need for external pumps and actuators. However, CCs optimized for high cohesion liquids (HCL) such as water are intrinsically unsuitable for programmed flow control of low cohesion liquids (LCL) such as oils and solvents because the high surface free energy needed for capillary flow of HCL results in uncontrolled, complete wetting by LCL. Here, we introduce a library of multiphase components including phase-to-phase valves (P2PV), hydro-pneumatic relays (HPR) and multiphase domino valves (MDVs) that collectively enable CCs to concomitantly process HCLs and LCLs. P2PVs use a pre-filled HCL to valve immiscible LCLs (e.g. oil) by confining the LCL, and upon triggering, hydraulically entrain it. To prevent uncontrolled mixing between miscible LCLs (e.g. ethanol) and the HCL, HPRs with an air gap and air waste are added to the P2PV. MDVs are further added and enable preprogrammed, sequential delivery of LCL and HCL by multiphase microfluidic chain reactions. Multiphase liquid processing is applied to automated, on-chip lipid nanoparticle (LNP) manufacturing, illustrating the potential of multiphase CCs.
- Open Access
- 4 June 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Co-enrichment of proteins in extracellular vesicles
Extracellular vesicles are cell-derived secretions that mediate tissue homeostasis and intercellular communication through their diverse cargos, including proteins. Distinct extracellular vesicle biogenesis pathways suggest specific association and co-enrichment of proteins sharing a biogenesis pathway, and non-association and co-depletion of proteins segregated into distinct pathways. Yet these associations elude conventional protein expression or co-expression measurements. Here, we propose and define pairwise protein co-enrichment relative to its overall expression to quantify whether a given protein is co-enriched or co-depleted with another protein. We measure co-enrichment, and differential co-enrichment between a stimulus and a reference condition, of up to 240 protein pairs in extracellular vesicles using antibody microarrays. We validate co-enrichment by modulating well-known extracellular vesicle biogenesis pathways, and find that differential co-enrichment measures expected changes between perturbed and reference conditions. Co-enrichment and differential co-enrichment in three model cell lines and parental and organotropic breast cancer progeny cell lines reveal both preserved and variable co-enrichment that may warrant further studies. Collectively, our result suggest that co-enrichment reflects cell physiology and extracellular biogenesis, is readily measurable, and could serve as quality control in extracellular vesicle biomanufacturing.
- 4 June 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessCo-enrichment of proteins in extracellular vesicles
Extracellular vesicles are cell-derived secretions that mediate tissue homeostasis and intercellular communication through their diverse cargos, including proteins. Distinct extracellular vesicle biogenesis pathways suggest specific association and co-enrichment of proteins sharing a biogenesis pathway, and non-association and co-depletion of proteins segregated into distinct pathways. Yet these associations elude conventional protein expression or co-expression measurements. Here, we propose and define pairwise protein co-enrichment relative to its overall expression to quantify whether a given protein is co-enriched or co-depleted with another protein. We measure co-enrichment, and differential co-enrichment between a stimulus and a reference condition, of up to 240 protein pairs in extracellular vesicles using antibody microarrays. We validate co-enrichment by modulating well-known extracellular vesicle biogenesis pathways, and find that differential co-enrichment measures expected changes between perturbed and reference conditions. Co-enrichment and differential co-enrichment in three model cell lines and parental and organotropic breast cancer progeny cell lines reveal both preserved and variable co-enrichment that may warrant further studies. Collectively, our result suggest that co-enrichment reflects cell physiology and extracellular biogenesis, is readily measurable, and could serve as quality control in extracellular vesicle biomanufacturing.
- Open Access
Iterative Extracellular Vesicle Protein Co-Expression Biomarker Refinement for Preoperative Classification of Histopathological Growth Patterns in Colorectal Liver Metastasis Patients
Preoperative triage of colorectal liver metastases (CRCLM) by histopathological growth pattern (HGP)—angiogenesis-dependent desmoplastic (dHGP) and vessel co-opting replacement (rHGP)—could guide anti-angiogenic therapy, yet HGP scoring requires resected tissue. We present an extracellular vesicle (EV) inner and outer protein (EVPio) co-expression assay and iterative biomarker refinement for plasma-based HGP classification. We established a minimal, high-throughput plasma pre-processing workflow (low-speed centrifugation and 0.45 μm filtration) with comparable EVPio assay performance to size-exclusion chromatography. We established an EV biomarker selection template with growing cohorts—feasibility ( n = 3), pilot ( n = 9), discovery ( n = 67)—ranking candidate protein pairs by signal quality (SNR, CV), redundancy (inter-correlation/orthogonality), and HGP separation (effect size, significance, ROC). This process reduced an initial 19×18 capture/detection set to a focused 9×9 panel (81 co-expression pairs). In a 58-patient CRCLM subset (22 dHGP, 14 rHGP, 22 mixed), three pairs achieved high signal quality with significant differential expression across HGPs. A three-feature linear discriminant model yielded 75.9% cross-validated accuracy (AUC 0.77) for classifying pure dHGP vs. non-dHGP. The results show that co-expression signatures capture defining features of HGP biology while revealing heterogeneity. The proposed EV biomarker refinement template is generalizable and our results show that co-expression signatures capture defining features of HGP biology supporting efforts towards clinically actionable, HGP-driven therapeutic guidance.
Open AccessIterative Extracellular Vesicle Protein Co-Expression Biomarker Refinement for Preoperative Classification of Histopathological Growth Patterns in Colorectal Liver Metastasis Patients
Preoperative triage of colorectal liver metastases (CRCLM) by histopathological growth pattern (HGP)—angiogenesis-dependent desmoplastic (dHGP) and vessel co-opting replacement (rHGP)—could guide anti-angiogenic therapy, yet HGP scoring requires resected tissue. We present an extracellular vesicle (EV) inner and outer protein (EVPio) co-expression assay and iterative biomarker refinement for plasma-based HGP classification. We established a minimal, high-throughput plasma pre-processing workflow (low-speed centrifugation and 0.45 μm filtration) with comparable EVPio assay performance to size-exclusion chromatography. We established an EV biomarker selection template with growing cohorts—feasibility ( n = 3), pilot ( n = 9), discovery ( n = 67)—ranking candidate protein pairs by signal quality (SNR, CV), redundancy (inter-correlation/orthogonality), and HGP separation (effect size, significance, ROC). This process reduced an initial 19×18 capture/detection set to a focused 9×9 panel (81 co-expression pairs). In a 58-patient CRCLM subset (22 dHGP, 14 rHGP, 22 mixed), three pairs achieved high signal quality with significant differential expression across HGPs. A three-feature linear discriminant model yielded 75.9% cross-validated accuracy (AUC 0.77) for classifying pure dHGP vs. non-dHGP. The results show that co-expression signatures capture defining features of HGP biology while revealing heterogeneity. The proposed EV biomarker refinement template is generalizable and our results show that co-expression signatures capture defining features of HGP biology supporting efforts towards clinically actionable, HGP-driven therapeutic guidance.
- Open Access
Microfluidic sieve and detector for rapid ultrasensitive assays with single-molecule sensitivity
The advent of ultrasensitive assays enabled many new research and clinical applications, but the time-to-result is hours and has not significantly improved over time, limiting their potential. We introduce the microfluidic sieve and detector (MFSD) that can sieve 200 microlitres in just one minute, and quantify captured analytes in four minutes, down to zeptomolar (10 -19 M) concentration. The MFSD comprises half a million 8-μm-diameter pores that bind analytes upon Brownian motion-induced wall collision. Conventional ensemble models and a stochastic Brownian agent dynamics introduced here reveal rapid, predictable and tuneable analyte capture under flow. Digital sandwich assays are completed by sequentially flowing the sample and reagents, partitioning the pores, and digitally revealing single ‘trapped’ analytes by enzymatic amplification. The MFSD tests are specific and reproducible, exhibit a large dynamic range, and are simple, tuneable and versatile, enabling measurement of different proteins including influenza A nucleoprotein in clinical samples, and even nucleic acids while being both faster and more sensitive than PCR. As such, the MFSD could open a new chapter for analysis and diagnostics.
Open AccessMicrofluidic sieve and detector for rapid ultrasensitive assays with single-molecule sensitivity
The advent of ultrasensitive assays enabled many new research and clinical applications, but the time-to-result is hours and has not significantly improved over time, limiting their potential. We introduce the microfluidic sieve and detector (MFSD) that can sieve 200 microlitres in just one minute, and quantify captured analytes in four minutes, down to zeptomolar (10 -19 M) concentration. The MFSD comprises half a million 8-μm-diameter pores that bind analytes upon Brownian motion-induced wall collision. Conventional ensemble models and a stochastic Brownian agent dynamics introduced here reveal rapid, predictable and tuneable analyte capture under flow. Digital sandwich assays are completed by sequentially flowing the sample and reagents, partitioning the pores, and digitally revealing single ‘trapped’ analytes by enzymatic amplification. The MFSD tests are specific and reproducible, exhibit a large dynamic range, and are simple, tuneable and versatile, enabling measurement of different proteins including influenza A nucleoprotein in clinical samples, and even nucleic acids while being both faster and more sensitive than PCR. As such, the MFSD could open a new chapter for analysis and diagnostics.
- Open Access
- 7 October 2025
- Published by Wiley in Advanced Materials
- Vol. 38 (13) , e06398
PiP‐Plex: A Particle‐in‐Particle System for Multiplexed Quantification of Proteins Secreted by Single Cells
Cell signaling is modulated by the secretion of various proteins, which can be used to infer a cell's phenotype. However, these proteins cannot be readily detected in multiplex by commonly used methods at the single‐cell level. Here we present PiP‐plex a particles‐in‐particle (PiPs) system for multiplex protein secretion analysis by confocal microscopy. PiP‐plex‐comprises (i) fluorescence intensity barcoded microparticles (BMPs) co‐entrapped with (ii) a single cell inside an alginate hydrogel particle. We found that PiPs maintained >90% cellular viability and allowed live cells retrieval. A seven‐plex fluorescent barcoding and concomitant sandwich immunoassay in PiPs was developed with limits of detection ranging from 0.8 pg mL −1 to 2 ng mL −1 depending on the protein. PiP‐plex assays were benchmarked with bulk immunoassays and found to rival or outperform them. Proteins secreted by single THP‐1 cells upon exposure to lipopolysaccharide were measured by PiP‐plex and varying cell responses detected, including a significant increase in MIP‐1α, TNF‐α, and IL‐17A; MIP‐1α and IL‐17A were the most frequently secreted cytokines, while other cytokines were typically co‐secreted. Using PiP‐plex, we analyzed ≈750 THP‐1 cells, showcasing its potential for characterizing cells and cell‐based therapeutics for e.g. cancer immunotherapies.
- 7 October 2025
- Published by Wiley in Advanced Materials
- Vol. 38 (13) , e06398
Open AccessPiP‐Plex: A Particle‐in‐Particle System for Multiplexed Quantification of Proteins Secreted by Single Cells
Cell signaling is modulated by the secretion of various proteins, which can be used to infer a cell's phenotype. However, these proteins cannot be readily detected in multiplex by commonly used methods at the single‐cell level. Here we present PiP‐plex a particles‐in‐particle (PiPs) system for multiplex protein secretion analysis by confocal microscopy. PiP‐plex‐comprises (i) fluorescence intensity barcoded microparticles (BMPs) co‐entrapped with (ii) a single cell inside an alginate hydrogel particle. We found that PiPs maintained >90% cellular viability and allowed live cells retrieval. A seven‐plex fluorescent barcoding and concomitant sandwich immunoassay in PiPs was developed with limits of detection ranging from 0.8 pg mL −1 to 2 ng mL −1 depending on the protein. PiP‐plex assays were benchmarked with bulk immunoassays and found to rival or outperform them. Proteins secreted by single THP‐1 cells upon exposure to lipopolysaccharide were measured by PiP‐plex and varying cell responses detected, including a significant increase in MIP‐1α, TNF‐α, and IL‐17A; MIP‐1α and IL‐17A were the most frequently secreted cytokines, while other cytokines were typically co‐secreted. Using PiP‐plex, we analyzed ≈750 THP‐1 cells, showcasing its potential for characterizing cells and cell‐based therapeutics for e.g. cancer immunotherapies.
- Open Access
PiP-plex: A Particle-in-Particle System for Multiplexed Quantification of Proteins Secreted by Single Cells
Cell signaling is modulated by the secretion of various proteins, which can be used to infer a cell’s phenotype. However, these proteins cannot be readily detected in multiplex by commonly used methods at the single cell level. Here, we present PiP-plex, a particles-in-particle (PiPs) system comprising (i) fluorescence intensity barcoded microparticles (BMPs) co-entrapped with (ii) a single cell inside an alginate hydrogel particle for multiplex protein secretion analysis by confocal microscopy. We show that developed PiPs maintained >90 % cellular viability and allowed live cells retrieval. A seven-plex fluorescent barcoding and concomitant sandwich immunoassay in PiPs were implemented with limits of detection ranging from 0.8 pg mL -1 to 2 ng mL -1 depending on the protein. PiP-plex assays were benchmarked with bulk immunoassays and found to rival or outperform them. We applied PiP-plex to analyze protein secreted by THP-1 cells upon exposure to lipopolysaccharide and detected varying cell responses, with a significant increase in MIP-1α, TNF-α and IL-17A. Multivariate analysis revealed that the majority of stimulated cells secreted either MIP-1α or IL-17A, while other cytokines were typically co-secreted. Using PiP-plex, we analyzed ∼750 THP-1 cells, showcasing its potential for characterizing cells and cell-based therapeutics for cancer immunotherapies.
Open AccessPiP-plex: A Particle-in-Particle System for Multiplexed Quantification of Proteins Secreted by Single Cells
Cell signaling is modulated by the secretion of various proteins, which can be used to infer a cell’s phenotype. However, these proteins cannot be readily detected in multiplex by commonly used methods at the single cell level. Here, we present PiP-plex, a particles-in-particle (PiPs) system comprising (i) fluorescence intensity barcoded microparticles (BMPs) co-entrapped with (ii) a single cell inside an alginate hydrogel particle for multiplex protein secretion analysis by confocal microscopy. We show that developed PiPs maintained >90 % cellular viability and allowed live cells retrieval. A seven-plex fluorescent barcoding and concomitant sandwich immunoassay in PiPs were implemented with limits of detection ranging from 0.8 pg mL -1 to 2 ng mL -1 depending on the protein. PiP-plex assays were benchmarked with bulk immunoassays and found to rival or outperform them. We applied PiP-plex to analyze protein secreted by THP-1 cells upon exposure to lipopolysaccharide and detected varying cell responses, with a significant increase in MIP-1α, TNF-α and IL-17A. Multivariate analysis revealed that the majority of stimulated cells secreted either MIP-1α or IL-17A, while other cytokines were typically co-secreted. Using PiP-plex, we analyzed ∼750 THP-1 cells, showcasing its potential for characterizing cells and cell-based therapeutics for cancer immunotherapies.
- Open Access
- 14 October 2024
- Published by Wiley in Journal of Extracellular Vesicles
- Vol. 13 (10) , e12512
Size photometry and fluorescence imaging of immobilized immersed extracellular vesicles
Immunofluorescence analysis of individual extracellular vesicles (EVs) in common fluorescence microscopes is gaining popularity due to its accessibility and high fluorescence sensitivity; however, EV number and size are only measurable using fluorescent stains requiring extensive sample manipulations. Here we introduce highly sensitive label‐free EV size photometry (SP) based on interferometric scattering (iSCAT) imaging of immersed EVs immobilized on a glass coverslip. We implement SP on a common inverted epifluorescence microscope with LED illumination and a simple 50:50 beamsplitter, permitting seamless integration of SP with fluorescence imaging (SPFI). We present a high‐throughput SPFI workflow recording >10,000 EVs in 7 min over ten 88 × 88 µm2 fields of view, pre‐ and post‐incubation imaging to suppress background, along with automated image alignment, aberration correction, spot detection and EV sizing. We achieve an EV sizing range from 37 to ∼220 nm in diameter with a dual 440 and 740 nm SP illumination scheme, and suggest that this range can be extended by more advanced image analysis or additional hardware customization. We benchmark SP to flow cytometry using calibrated silica nanoparticles and demonstrate superior, label‐free sensitivity. We showcase SPFI's potential for EV analysis by experimentally distinguishing surface and volumetric EV dyes, observing the deformation of EVs adsorbed to a surface, and by uncovering distinct subpopulations in <100 nm‐in‐diameter EVs with fluorescently tagged membrane proteins.
- 14 October 2024
- Published by Wiley in Journal of Extracellular Vesicles
- Vol. 13 (10) , e12512
Open AccessSize photometry and fluorescence imaging of immobilized immersed extracellular vesicles
Immunofluorescence analysis of individual extracellular vesicles (EVs) in common fluorescence microscopes is gaining popularity due to its accessibility and high fluorescence sensitivity; however, EV number and size are only measurable using fluorescent stains requiring extensive sample manipulations. Here we introduce highly sensitive label‐free EV size photometry (SP) based on interferometric scattering (iSCAT) imaging of immersed EVs immobilized on a glass coverslip. We implement SP on a common inverted epifluorescence microscope with LED illumination and a simple 50:50 beamsplitter, permitting seamless integration of SP with fluorescence imaging (SPFI). We present a high‐throughput SPFI workflow recording >10,000 EVs in 7 min over ten 88 × 88 µm2 fields of view, pre‐ and post‐incubation imaging to suppress background, along with automated image alignment, aberration correction, spot detection and EV sizing. We achieve an EV sizing range from 37 to ∼220 nm in diameter with a dual 440 and 740 nm SP illumination scheme, and suggest that this range can be extended by more advanced image analysis or additional hardware customization. We benchmark SP to flow cytometry using calibrated silica nanoparticles and demonstrate superior, label‐free sensitivity. We showcase SPFI's potential for EV analysis by experimentally distinguishing surface and volumetric EV dyes, observing the deformation of EVs adsorbed to a surface, and by uncovering distinct subpopulations in <100 nm‐in‐diameter EVs with fluorescently tagged membrane proteins.
- Open Access
- 3 June 2024
- Published by Wiley in Advanced Functional Materials
- Vol. 34 (28)
Nanoporous, Gas Permeable PEGDA Ink for 3D Printing Organ‐on‐a‐Chip Devices
Polydimethylsiloxane (PDMS), commonly used in organ‐on‐a‐chip (OoC) systems, faces limitations in replicating complex geometries, hindering its effectiveness in creating 3D OoC models. In contrast, poly(ethylene glycol)diacrylate (PEGDA‐250), favored for its fabrication ease and resistance to small molecule absorption, is increasingly used for 3D printing microfluidic devices. However, applications in cell culture have been limited due to poor cell adhesion. Here, a nanoporous PEGDA ink (P‐PEGDA) is introduced to enhance cell adhesion. P‐PEGDA is formulated with a porogen, photopolymerized, followed by the porogen removal. Utilizing P‐PEGDA, complex microstructures, and membranes as thin as 27 µm are 3D‐printed. Porogen concentrations from 10 to 30% are tested yielding constructs with increasing porosity and oxygen permeability surpassing PDMS, without compromising printing resolution. Tests across four cell lines show >80% cell viability, with a notable 77‐fold increase in MDA‐MB‐231 cell coverage on the porous scaffolds. Finally, an OoC model comprising a gyroid scaffold with a central opening filled with a cancer spheroid is introduced. This setup, after a 14 days co‐culture, demonstrates significant endothelial sprouting and integration within the spheroid. The P‐PEGDA formulation is suitable for high‐resolution 3D printing of constructs for 3D cell culture and OoC owing to its printability, gas permeability, biocompatibility, and cell adhesion.
- 3 June 2024
- Published by Wiley in Advanced Functional Materials
- Vol. 34 (28)
Open AccessNanoporous, Gas Permeable PEGDA Ink for 3D Printing Organ‐on‐a‐Chip Devices
Polydimethylsiloxane (PDMS), commonly used in organ‐on‐a‐chip (OoC) systems, faces limitations in replicating complex geometries, hindering its effectiveness in creating 3D OoC models. In contrast, poly(ethylene glycol)diacrylate (PEGDA‐250), favored for its fabrication ease and resistance to small molecule absorption, is increasingly used for 3D printing microfluidic devices. However, applications in cell culture have been limited due to poor cell adhesion. Here, a nanoporous PEGDA ink (P‐PEGDA) is introduced to enhance cell adhesion. P‐PEGDA is formulated with a porogen, photopolymerized, followed by the porogen removal. Utilizing P‐PEGDA, complex microstructures, and membranes as thin as 27 µm are 3D‐printed. Porogen concentrations from 10 to 30% are tested yielding constructs with increasing porosity and oxygen permeability surpassing PDMS, without compromising printing resolution. Tests across four cell lines show >80% cell viability, with a notable 77‐fold increase in MDA‐MB‐231 cell coverage on the porous scaffolds. Finally, an OoC model comprising a gyroid scaffold with a central opening filled with a cancer spheroid is introduced. This setup, after a 14 days co‐culture, demonstrates significant endothelial sprouting and integration within the spheroid. The P‐PEGDA formulation is suitable for high‐resolution 3D printing of constructs for 3D cell culture and OoC owing to its printability, gas permeability, biocompatibility, and cell adhesion.
- Open Access
- 4 March 2024
- Published by American Chemical Society (ACS) in ACS Sensors
- Vol. 9 (3) , 1239-1251
Effect of Sample Preprocessing and Size-Based Extraction Methods on the Physical and Molecular Profiles of Extracellular Vesicles
Extracellular vesicles (EVs) are nanometric lipid vesicles that shuttle cargo between cells. Their analysis could shed light on health and disease conditions, but EVs must first be preserved, extracted, and often preconcentrated. Here we first compare plasma preservation agents, and second, using both plasma and cell supernatant, four EV extraction methods, including (i) ultracentrifugation (UC), (ii) size-exclusion chromatography (SEC), (iii) centrifugal filtration (LoDF), and (iv) accousto-sorting (AcS). We benchmarked them by characterizing the integrity, size distribution, concentration, purity, and expression profiles for nine proteins of EVs, as well as the overall throughput, time-to-result, and cost. We found that the difference between ethylenediaminetetraacetic acid (EDTA) and citrate anticoagulants varies with the extraction method. In our hands, ultracentrifugation produced a high yield of EVs with low contamination; SEC is low-cost, fast, and easy to implement, but the purity of EVs is lower; LoDF and AcS are both compatible with process automation, small volume requirement, and rapid processing times. When using plasma, LoDF was susceptible to clogging and sample contamination, while AcS featured high purity but a lower yield of extraction. Analysis of protein profiles suggests that the extraction methods extract different subpopulations of EVs. Our study highlights the strengths and weaknesses of sample preprocessing methods, and the variability in concentration, purity, and EV expression profiles of the extracted EVs. Preanalytical parameters such as collection or preprocessing protocols must be considered as part of the entire process in order to address EV diversity and their use as clinically actionable indicators.
- 4 March 2024
- Published by American Chemical Society (ACS) in ACS Sensors
- Vol. 9 (3) , 1239-1251
Open AccessEffect of Sample Preprocessing and Size-Based Extraction Methods on the Physical and Molecular Profiles of Extracellular Vesicles
Extracellular vesicles (EVs) are nanometric lipid vesicles that shuttle cargo between cells. Their analysis could shed light on health and disease conditions, but EVs must first be preserved, extracted, and often preconcentrated. Here we first compare plasma preservation agents, and second, using both plasma and cell supernatant, four EV extraction methods, including (i) ultracentrifugation (UC), (ii) size-exclusion chromatography (SEC), (iii) centrifugal filtration (LoDF), and (iv) accousto-sorting (AcS). We benchmarked them by characterizing the integrity, size distribution, concentration, purity, and expression profiles for nine proteins of EVs, as well as the overall throughput, time-to-result, and cost. We found that the difference between ethylenediaminetetraacetic acid (EDTA) and citrate anticoagulants varies with the extraction method. In our hands, ultracentrifugation produced a high yield of EVs with low contamination; SEC is low-cost, fast, and easy to implement, but the purity of EVs is lower; LoDF and AcS are both compatible with process automation, small volume requirement, and rapid processing times. When using plasma, LoDF was susceptible to clogging and sample contamination, while AcS featured high purity but a lower yield of extraction. Analysis of protein profiles suggests that the extraction methods extract different subpopulations of EVs. Our study highlights the strengths and weaknesses of sample preprocessing methods, and the variability in concentration, purity, and EV expression profiles of the extracted EVs. Preanalytical parameters such as collection or preprocessing protocols must be considered as part of the entire process in order to address EV diversity and their use as clinically actionable indicators.
- Open Access
Size photometry and fluorescence imaging of immobilized immersed extracellular vesicles
Immunofluorescence analysis of individual extracellular vesicles (EVs) in common fluorescence microscopes is gaining popularity due to its accessibility and high fluorescence sensitivity, however, EV number and size are only measurable using fluorescent stains requiring extensive sample manipulations. Here we introduce highly sensitive label-free EV size photometry (SP) based on interferometric scattering (iSCAT) imaging of immersed EVs immobilized on a glass coverslip. We implement SP on a common inverted epifluorescence microscope with LED illumination and a simple 50:50 beamsplitter, permitting seamless integration of SP with fluorescence imaging (SPFI). We present a high-throughput SPFI workflow recording >10,000 EVs in 7 min over multiple fields of view, pre- and post-incubation imaging to suppress background, along with automated image alignment, aberration correction, spot detection, and EV sizing. We identify the upper sizing limit of SP with 440 nm illumination and extend EVs sizing from ∼37 nm in diameter to >200 nm with dual 440 nm and 740 nm illumination. We benchmark SP to flow cytometry using calibrated silica nanoparticles and demonstrate superior, label-free sensitivity. We showcase SPFI’s potential for EV analysis by experimentally distinguishing surface and volumetric EV dyes, observing the deformation of EVs adsorbed to a surface, and by uncovering distinct subpopulations in <100 nm-in-diameter EVs with fluorescently tagged membrane proteins.
Open AccessSize photometry and fluorescence imaging of immobilized immersed extracellular vesicles
Immunofluorescence analysis of individual extracellular vesicles (EVs) in common fluorescence microscopes is gaining popularity due to its accessibility and high fluorescence sensitivity, however, EV number and size are only measurable using fluorescent stains requiring extensive sample manipulations. Here we introduce highly sensitive label-free EV size photometry (SP) based on interferometric scattering (iSCAT) imaging of immersed EVs immobilized on a glass coverslip. We implement SP on a common inverted epifluorescence microscope with LED illumination and a simple 50:50 beamsplitter, permitting seamless integration of SP with fluorescence imaging (SPFI). We present a high-throughput SPFI workflow recording >10,000 EVs in 7 min over multiple fields of view, pre- and post-incubation imaging to suppress background, along with automated image alignment, aberration correction, spot detection, and EV sizing. We identify the upper sizing limit of SP with 440 nm illumination and extend EVs sizing from ∼37 nm in diameter to >200 nm with dual 440 nm and 740 nm illumination. We benchmark SP to flow cytometry using calibrated silica nanoparticles and demonstrate superior, label-free sensitivity. We showcase SPFI’s potential for EV analysis by experimentally distinguishing surface and volumetric EV dyes, observing the deformation of EVs adsorbed to a surface, and by uncovering distinct subpopulations in <100 nm-in-diameter EVs with fluorescently tagged membrane proteins.